PT-141 10MG

Description

PT-141, also known as Bremelanotide, is a modified cyclic heptapeptide supplied for controlled laboratory, analytical, and scientific research.

Its molecular identity includes N-terminal acetylation, norleucine, D-phenylalanine, and intramolecular lactam cyclization. These structural features are integral to the molecule and distinguish PT-141 from conventional linear peptides.

For accurate technical documentation, the exact salt or counter-ion form, purity specification, and lot-specific analytical profile should be confirmed using the applicable Certificate of Analysis.

Research Applications

PT-141 may be examined in controlled non-clinical research involving:

• Cyclic peptide characterization
• Ligand-receptor interaction studies
• Molecular signaling research
• Modified amino-acid characterization
• Structure-function analysis
• Analytical peptide comparison
• Stability assessment
• Non-clinical biochemical and cellular models

Experimental findings should remain specific to the applicable research system and should not be interpreted as evidence of behavioral, reproductive, therapeutic, or clinical effectiveness.

Structural Information

PT-141 is commonly represented as:

Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Key structural characteristics include:

• Seven amino-acid residues
• N-terminal acetylation
• Norleucine residue
• D-phenylalanine residue
• Intramolecular lactam cyclization
• Free C-terminal carboxyl group

Because PT-141 contains non-standard residues, defined stereochemistry, and cyclization, a conventional one-letter sequence alone does not fully describe its molecular identity.

Analytical Identification

Relevant analytical characterization may include:

• Peptide identity confirmation
• Molecular mass assessment
• Cyclization verification
• Modified-residue confirmation
• Stereochemical verification
• Chromatographic purity testing
• Structural characterization
• Lot-specific quality analysis

Specifications & Documentation

Lot-specific documentation should be reviewed for:

• PT-141 / Bremelanotide identity
• CAS number
• Molecular formula
• Molecular weight
• Peptide structure
• Modified residues
• Cyclization
• Terminal modifications
• Salt or counter-ion form
• Purity specification
• Analytical testing
• Lot or batch information
• Certificate of Analysis
• Storage requirements

Authenticated product-specific documentation should take precedence over generalized reference values.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Follow established laboratory procedures appropriate for modified research peptide materials.

Research Use Only

PT-141 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, behavioral use, reproductive use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, behavioral, reproductive, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.